1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Szolajska, E. Poznanski, J. Ferber, M.L. Michalik, J. Gout, E. Fender, P. Bailly, I. Dublet, B. Chroboczek, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 271 2127 2136 10.1111/j.1432-1033.2004.04128.x 15153103 Poneratoxin, a neurotoxin from ant venom. Structure and expression in insect cells and construction of a bio-insecticide. 2004 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2759.355 PONERATOXIN 1 syn polymer PAC-TX no no FLPLLILGSLLMTPPVIQAIHDAQR FLPLLILGSLLMTPPVIQAIHDAQR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release Version format compliance Version format compliance 1 0 2003-11-18 1 1 2008-04-27 1 2 2011-07-13 RCSB Y RCSB 2000-11-22 REL REL The peptide was chemically synthesized. The sequence of the peptide is naturally found in Paraponera clavata (Venon ant). sample This structure was determined using standard 2D homonuclear techniques. 100 and 200 ms mixing time 2D-NOESY spectra were accumulated target function 333 10 DQF-COSY 2D NOESY TOCSY 5.5 1 atm 298 K The structures are based on 428 NOE-derived distance restraints and 20 dihedral angle restraints. Simulated annealing in the REDAC strategy made by DYANA. Final refinement, inculding PRO pyrrolidine ring puckering by X-PLOR. simulated annealing 1 lowest energy 3 mM of C-amidated peptide D2O:TFE in volumetric ratio 3:1 Bruker collection UXNMR 930601.3 Delaglio, Grzesiek, Vuister, Zhu, Pfeifer, Bax processing NMRPipe 1.7 Bartels, Xia, Guntert, Billeter, Wuthrich data analysis XEasy 1.3.11 Guntert, Mumenthaler structure solution DYANA 1.5 Brunger refinement X-PLOR 3.1 Biosym data analysis SYBYL 6.5 600 Bruker AMX PHE 1 n 1 PHE 1 A LEU 2 n 2 LEU 2 A PRO 3 n 3 PRO 3 A LEU 4 n 4 LEU 4 A LEU 5 n 5 LEU 5 A ILE 6 n 6 ILE 6 A LEU 7 n 7 LEU 7 A GLY 8 n 8 GLY 8 A SER 9 n 9 SER 9 A LEU 10 n 10 LEU 10 A LEU 11 n 11 LEU 11 A MET 12 n 12 MET 12 A THR 13 n 13 THR 13 A PRO 14 n 14 PRO 14 A PRO 15 n 15 PRO 15 A VAL 16 n 16 VAL 16 A ILE 17 n 17 ILE 17 A GLN 18 n 18 GLN 18 A ALA 19 n 19 ALA 19 A ILE 20 n 20 ILE 20 A HIS 21 n 21 HIS 21 A ASP 22 n 22 ASP 22 A ALA 23 n 23 ALA 23 A GLN 24 n 24 GLN 24 A ARG 25 n 25 ARG 25 A 1 A A O H PHE LEU 1 5 1.16 1 A A HA HD21 PHE LEU 1 5 1.33 1 A A O H VAL GLN 16 18 1.57 1 A A OD1 NH2 ASP ARG 22 25 2.06 1 A A CD1 OE1 LEU GLN 2 18 2.12 1 A A O N PHE LEU 1 5 2.15 2 A A HG21 HD12 ILE ILE 6 17 1.18 2 A A O H HIS ARG 21 25 1.22 2 A A O H PRO ALA 15 19 1.33 2 A A HA CD1 ILE ILE 6 17 1.52 3 A A HA HB2 PHE LEU 1 5 0.86 3 A A HB3 HD3 LEU PRO 2 3 1.11 3 A A O H PHE LEU 1 5 1.19 3 A A O H PRO ALA 15 19 1.49 3 A A O N PHE LEU 1 5 2.16 3 A A OG O SER THR 9 13 2.16 4 A A O H HIS ARG 21 25 0.87 4 A A HG O SER THR 9 13 1.02 4 A A HB3 HD3 LEU PRO 2 3 1.34 4 A A O H PRO ALA 15 19 1.42 4 A A O N HIS ARG 21 25 1.71 4 A A OG O SER THR 9 13 1.89 5 A A HG22 HD13 ILE ILE 6 17 0.94 5 A A HG22 CD1 ILE ILE 6 17 0.98 5 A A O H PHE LEU 1 5 1.13 5 A A HG23 HD11 ILE ILE 6 17 1.16 5 A A HG22 HD12 ILE ILE 6 17 1.21 5 A A HA HD21 PHE LEU 1 5 1.21 5 A A O H HIS ARG 21 25 1.22 5 A A O H PRO ALA 15 19 1.27 5 A A CG2 HD11 ILE ILE 6 17 1.51 5 A A CG2 CD1 ILE ILE 6 17 1.79 5 A A O N PHE LEU 1 5 2.12 6 A A HG23 HD12 ILE ILE 6 17 1.10 6 A A O H PRO ALA 15 19 1.18 6 A A O HG12 LEU ILE 2 6 1.52 6 A A O N PRO ALA 15 19 2.06 7 A A O H HIS ARG 21 25 1.28 7 A A O H PRO ALA 15 19 1.33 8 A A HD2 H PHE LEU 1 4 1.12 8 A A O H SER THR 9 13 1.45 8 A A O H HIS ARG 21 25 1.58 9 A A HD2 H PHE LEU 1 4 1.28 9 A A HB3 HD3 LEU PRO 2 3 1.30 9 A A O H PRO ALA 15 19 1.46 9 A A O H PRO LEU 3 7 1.49 9 A A O H VAL ILE 16 20 1.58 9 A A ND1 NH2 HIS ARG 21 25 2.12 10 A A HB HG3 ILE PRO 6 15 0.93 10 A A O H PHE LEU 1 5 1.13 10 A A HA HD23 PHE LEU 1 5 1.20 10 A A HD2 NH2 HIS ARG 21 25 1.46 10 A A O H PRO ALA 15 19 1.50 10 A A O HE HIS ARG 21 25 1.56 10 A A O H LEU GLY 4 8 1.56 10 A A CD2 NH2 HIS ARG 21 25 2.01 10 A A O N PHE LEU 1 5 2.12 1 A LEU 2 -20.69 -58.06 1 A LEU 11 -127.50 -68.83 1 A ILE 17 70.59 -52.41 2 A LEU 2 170.59 -51.00 2 A LEU 11 -94.72 -64.79 3 A LEU 2 4.91 -72.18 3 A LEU 11 58.33 15.42 3 A MET 12 -148.09 -74.88 4 A MET 12 -141.52 -61.05 5 A LEU 2 -18.38 -60.33 6 A LEU 2 -101.03 -67.40 6 A LEU 4 86.11 29.37 6 A LEU 5 -158.93 -49.62 7 A LEU 2 176.69 -58.83 7 A LEU 10 -111.21 75.76 7 A MET 12 -129.93 -55.40 8 A LEU 2 -104.50 -67.00 8 A MET 12 -133.65 -60.41 9 A LEU 2 -106.68 -69.86 9 A LEU 11 -160.38 -66.37 10 A LEU 2 -17.09 -61.60 10 A LEU 10 -96.09 56.10 PONERATOXIN SOLUTION STRUCTURE OF PONERATOXIN 1 N N A PHE 1 A PHE 1 HELX_P A SER 9 A SER 9 1 1 9 A GLN 18 A GLN 18 HELX_P A ARG 25 A ARG 25 1 2 8 TOXIN Toxin; Neurotoxin; Sodium channel inhibitor, TOXIN POTX_PARCV UNP 1 1 P41736 FLPLLILGSLLMTPPVIQAIHDAQR 1 25 1G92 1 25 P41736 A 1 1 25